Bio-Bridge Science’s HPV vaccine is designed to prevent HPV infections. Our HPV vaccine will be an oral vaccine that induces mucosal and systemic antibodies against HPV type 16, 18, 31, 45 and 58. This vaccine is still in laboratory animal experimental stage. Our subsidiary, Bio-Bridge Science (Beijing), plans to produce the HPV vaccine in our Research and Development facility in Beijing and conduct pre-clinical testing on the vaccine in 2010. Bio-Bridge Science (Beijing) will apply to China's State Food and Drug Administration for approval to conduct clinical trials on the vaccine after the pre-clinical testing is completed.